Kumamoto Y, Hirose T, Tanaka N, Hikichi Y, Shigeta S, Shiraiwa Y, Kameoka H, Yoshida H, Ogata M, Tazaki H
Department of Urology, School of Medicine, Sapporo Medical College.
Jpn J Antibiot. 1995 Oct;48(10):1394-421.
The frequencies of isolation and susceptibilities to antimicrobial agents were investigated on 751 bacterial strains isolated from patients with urinary tract infections in 11 hospitals during the period of June 1991 to May 1992. Of the above total bacterial isolates, Gram-positive bacteria accounted for 28.6% and a majority of them were Enterococcus faecalis. Gram-negative bacteria accounted for 71.4% and most of them were Escherichia coli. 1. Enterococcus faecalis Ampicillin (ABPC), imipenem (IPM) and vancomycin (VCM) showed the highest activities against E. faecalis isolated from patients with urinary tract infections. The MIC90s of them were 2 micrograms/ml. Piperacillin (PIPC) and chloramphenicol (CP) were also active with the MIC90s of 8 micrograms/ml. The others were not so active with the MIC90s of 32 micrograms/ml or above. 2. Staphylococcus aureus including MRSA Arbekacin (ABK) showed the highest activities against S. aureus isolated from patients with urinary tract infections. Its MIC90 was 0.5 microgram/ml. VCM was also active with its MIC90 of 1 microgram/ml. The others were not so active with the MIC90s of 32 micrograms/ml or above. 3. Citrobacter freundii Ciprofloxacin (CPFX) showed the highest activities against C. freundii isolated from patients with urinary tract infections. Its MIC90 was 0.5 microgram/ml. IPM, gentamicin (GM), ABK and norfloxacin (NFLX) were also active with the MIC90s of 1 microgram/ml. Penicillins and cephems were not so active. 4. Enterobacter cloacae IPM showed the highest activities against E. cloacae isolated from patients with urinary tract infections. Its MIC90 was 0.5 microgram/ml. CPFX was also active with the MIC90 of 2 micrograms/ml. Aminoglycosides were active comparatively. The MIC90s of them were 4 micrograms/ml. Penicillins and cephems generally showed lower activities. 5. Escherichia coli IPM and ciprofloxacin (CPFX) showed the highest activities against E. coli isolated from patients with urinary tract infections. The MIC90s of them were 0.125 micrograms/ml or below. Flomoxef (FMOX), cefmenoxime (CMX), cefuzonam (CZON), latamoxef (LMOX), norfloxacin (NFLX) and ofloxacin (OFLX) were also active with the MIC90s of 0.25 microgram/ml. Penicillins except mecillinam (MPC) were not so active showing the MIC90s of 32 micrograms/ml or above. 6. Klebsiella pneumoniae IPM showed the highest activities against K. pneumoniae isolated from patients with urinary tract infections. Its MIC90 was 0.25 microgram/ml. Gentamicin (GM) and arbekacin (ABK) were also active with the MIC90s of 0.5 microgram/ml, respectively. But minocycline (MINO) and penicillins were not so active showing the MIC90s of 32 micrograms/ml or above. 7. Proteus mirabilis Most of the agents were active against P. mirabilis.(ABSTRACT TRUNCATED AT 400 WORDS)
对1991年6月至1992年5月期间从11家医院的尿路感染患者中分离出的751株细菌菌株,进行了抗菌药物的分离频率和敏感性调查。在上述全部细菌分离株中,革兰氏阳性菌占28.6%,其中大多数是粪肠球菌。革兰氏阴性菌占71.4%,其中大多数是大肠杆菌。1. 粪肠球菌氨苄西林(ABPC)、亚胺培南(IPM)和万古霉素(VCM)对从尿路感染患者中分离出的粪肠球菌显示出最高活性。它们的MIC90为2微克/毫升。哌拉西林(PIPC)和氯霉素(CP)也有活性,MIC90为8微克/毫升。其他药物活性不高,MIC90为32微克/毫升或更高。2. 包括耐甲氧西林金黄色葡萄球菌(MRSA)在内的金黄色葡萄球菌阿贝卡星(ABK)对从尿路感染患者中分离出的金黄色葡萄球菌显示出最高活性。其MIC90为0.5微克/毫升。VCM也有活性,MIC90为1微克/毫升。其他药物活性不高,MIC90为32微克/毫升或更高。3. 弗氏柠檬酸杆菌环丙沙星(CPFX)对从尿路感染患者中分离出的弗氏柠檬酸杆菌显示出最高活性。其MIC90为0.5微克/毫升。IPM、庆大霉素(GM)、ABK和诺氟沙星(NFLX)也有活性,MIC90为1微克/毫升。青霉素类和头孢菌素类活性不高。4. 阴沟肠杆菌IPM对从尿路感染患者中分离出的阴沟肠杆菌显示出最高活性。其MIC90为0.5微克/毫升。CPFX也有活性,MIC90为2微克/毫升。氨基糖苷类相对有活性。它们的MIC90为4微克/毫升。青霉素类和头孢菌素类一般活性较低。5. 大肠杆菌IPM和环丙沙星(CPFX)对从尿路感染患者中分离出的大肠杆菌显示出最高活性。它们的MIC90为0.125微克/毫升或更低。氟氧头孢(FMOX)、头孢甲肟(CMX)、头孢唑南(CZON)、拉氧头孢(LMOX)、诺氟沙星(NFLX)和氧氟沙星(OFLX)也有活性,MIC90为0.25微克/毫升。除美西林(MPC)外的青霉素类活性不高,MIC90为32微克/毫升或更高。6. 肺炎克雷伯菌IPM对从尿路感染患者中分离出的肺炎克雷伯菌显示出最高活性。其MIC